Ainos

Ainos Tangible Book Value per Share

The Tangible Book Value per Share of Ainos (AIMD) as of Oct 15, 2026 is 1.08 USD. In the previous year, Tangible Book Value per Share was -1.18 USD — a change of -191.87% (higher).

Tangible Book Value per Share

1.08USD

YoY

-191.87%

Last updated:

Tangible Book Value per Share of Ainos is 2025 1.08 USD. Tangible Book Value per Share of Ainos was 2024 -1.18 USD. It decreases by -191.87% higher compared to the previous year.

The Ainos Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
0.08 USD
Jan 1, 2019
-0.04 USD
Jan 1, 2020
-0.15 USD
Jan 1, 2021
-3.89 USD
Jan 1, 2022
0.26 USD
Jan 1, 2023
-0.55 USD
Jan 1, 2024
-1.18 USD
Jan 1, 2025
1.08 USD
The Ainos Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
1.08USD-191.87%
-1.18USD+114.62%
-0.55USD-310.98%
0.26USD-106.70%
-3.89USD+2,564.59%
-0.15USD+232.03%
-0.04USD-152.87%
0.08USD+99.48%
0.04USD-129.98%
-0.14USD+78.93%
-0.08USD+348.93%
-0.02USD-100.00%
-473.28USD+15.74%
-408.91USD-2.48%
-419.32USD+3.09%
-406.76USD-39.03%
-667.12USD+8.33%
-615.84USD-5.22%
-649.76USD-10.23%
-723.84USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ainos Stock analysis

What does Ainos do? Ainos Inc, a U.S.-based biotechnology company headquartered in San Diego, California, operates in the health care sector. The company, which went public on August 8, 1996, currently employs 43 full-time staff. Ainos Inc focuses on developing medical technologies for point-of-care testing and medical treatments across various disease indications. The company's research and development activities include securing intellectual property and commercializing therapeutics, particularly those utilizing low-dose non-injectable interferon (IFN). Among its product offerings are the COVID-19 Antigen Rapid Test Kit, VOC POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, VELDONA (Very Low-Dose Oral Interferon Alpha), and Synthetic RNA (SRNA). The VOC POCT-Ainos Flora device is designed for non-invasive testing related to female vaginal health and certain sexually transmitted diseases. The VOC POCT-Ainos Pen is a portable, cloud-connected breath analyzer intended for health monitoring. The VOC POCT-CHS430 device aims to provide non-invasive testing for ventilator-associated pneumonia. Ainos Inc's website is www.ainos.com. The company's operational focus remains on advancing medical technologies for point-of-care applications. Ainos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ainos stock

Tangible Book Value per Share of Ainos is 1.08 USD in 2025.

Tangible Book Value per Share of Ainos changed from -1.18 USD to 1.08 USD, representing a -191.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Ainos since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Ainos

All Key Metrics — Ainos